Integrated Telehealth or In-Person Palliative Care in Improving Quality of Life in Patients with Advanced Non-small Cell Lung Cancer

Status: closed to accrual

This randomized clinical trial studies how well integrated telehealth or in-person palliative care works in improving quality of life in patients with non-small lung cancer that has spread to other places in the body (advanced). Early involvement in palliative care may lesson many of the distressing physical and emotional symptoms and help patients and their families cope with serious illness as well as improve patients’ and their loved ones’ experience with cancer. Integrated telehealth palliative care involves patients meeting with palliative care clinicians using secure video-conferencing technology. It is not yet known whether giving integrated telehealth or in-person palliative care works better for patients and their families in improving quality of life.

Inclusion Criteria

PATIENT: Diagnosed with advanced non-small cell lung carcinoma (NSCLC) being treated with non-curative intent, and informed of advanced disease within the prior twelve weeks
PATIENT: Eastern Cooperative Oncology Group (ECOG) performance status from 0 (asymptomatic) to 3 (symptomatic and in bed > 50% of the day)
PATIENT: The ability to read and respond to questions in English or Spanish
PATIENT: Receiving primary cancer care at one of the participating sites
PATIENT: Age >= 18 years
CAREGIVER: Relative or friend who is identified by the patient participant and lives with the patient or has contact with them at least twice per week
CAREGIVER: The ability to read and respond to questions in English or Spanish
CAREGIVER: Age >= 18 years

Exclusion Criteria

PATIENT: They are already receiving outpatient PC or hospice services
PATIENT: They have cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation
CAREGIVER: They have cognitive or psychiatric conditions as determined by the treating oncologist to prohibit study consent or participation

PRIMARY OBJECTIVE:

I. To determine whether telehealth palliative care (PC) is equivalent to in-person PC for improving patients’ quality of life (QOL).

SECONDARY OBJECTIVES:

I. To determine whether telehealth PC is equivalent to in-person PC with respect to patient-clinician communication about end of life (EOL) care preferences and length of stay in hospice.

II. To compare the effect of telehealth versus in-person PC on caregiver participation in PC visits.

III. To compare patient and caregiver satisfaction with telehealth versus in-person PC.

EXPLORATORY OBJECTIVES:

I. To compare coping strategies in patients assigned to telehealth versus in- person PC.

II. To compare prognostic understanding in patients and caregivers assigned to telehealth.

III. To compare the effect of telehealth versus in person PC on caregivers’ outcomes, including QOL and mood.

IV. To compare the effect of telehealth versus in-person PC on patients’ mood.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP I: Patients receive video-conference palliative care every 4 weeks over 30 minutes.

GROUP II: Patients receive in-person palliative care every 4 weeks over 30 minutes.

After completion of study, patients are followed periodically.

Have a question?
We're here to help

Chat with us: LiveHelp
Call us: 1-800-4-CANCER
(1-800-422-6237)

Which trials are right for you?

Use the checklist in our guide to gather the information you’ll need.

Integrated Telehealth or In-Person Palliative Care in Improving Quality of Life in Patients with Advanced Non-small Cell Lung Cancer

Description

Eligibility Criteria

Locations & Contacts

Trial Objectives and Outline

Trial Phase & Type

Lead Organization

Trial IDs

Have a question?We're here to help

Which trials are right for you?

Have a question?
We're here to help